Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

1(33%)

Results Posted

100%(1 trials)

Phase Distribution

Ph not_applicable

33%

Ph phase_2

33%

Ph phase_4

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 2Efficacy & side effects

1(33.3%)

Phase 4Post-market surveillance

1(33.3%)

N/ANon-phased studies

1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(1)

Other(1)

Detailed Status

Active, not recruiting1

unknown1

Completed1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 21 (33.3%)

Phase 41 (33.3%)

N/A1 (33.3%)

Trials by Status

active_not_recruiting133%

unknown133%

completed133%

Recent Activity

1 active trials

Showing 3 of 3

unknownnot_applicable

Effectiveness of Antibiotics Versus Placebo to Treat Antenatal Hydronephrosis

NCT01140516

active_not_recruitingphase_2

Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants

NCT03107871

completedphase_4

Pain Control in Pediatric Posterior Spine Fusion Patients: The Effect of Gabapentin

NCT01977937

Clinical Trials (3)

Showing 3 of 3 trials

NCT01140516Not Applicable

Effectiveness of Antibiotics Versus Placebo to Treat Antenatal Hydronephrosis

Unknown

NCT03107871Phase 2

Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants

Active Not Recruiting

NCT01977937Phase 4

Pain Control in Pediatric Posterior Spine Fusion Patients: The Effect of Gabapentin

Completed

All 3 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 3